Patent directory · USPTO A61K / A61P
Patents matching “REGENERON PHARMACEUTICALS, INC.”
837 pharma patents match "REGENERON PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 837 pharmaceutical patents matching "REGENERON PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10745471
Method of treating osteoarthritis with an antibody to NGF
granted -
US 10736976
Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging
granted -
US 10736961
Method of averting opioid addiction
granted -
US 10738124
Anti-EGFRvIII antibodies and uses thereof
granted -
US 10738126
Anti-GITR antibodies and uses thereof
granted -
US 10738130
Bispecific antigen-binding molecules that bind MUC16 and CD3, and compositions thereof
granted -
US 10737113
Human antibodies to PD-1
granted -
US 10730948
Methods for treating eosinophilic esophagitis by administering an IL-4R inhibitor
granted -
US 10730944
Anti-CD8 antibodies and uses thereof
granted -
US 10711032
Steroids and protein-conjugates thereof
granted -
US 10689436
Human antibodies to influenza hemagglutinin
granted -
US 10683354
Antibody-drug conjugates comprising anti-prolactin receptor (PRLR) antibodies and methods of use thereof to kill PRLR-expressing cells
granted -
US 10676530
Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an antibody to IL-4 receptor
granted -
US 10662244
Methods for tumor treatment using CD3XCD20 bispecific antibody
granted -
US 10640566
Nucleic acid molecules encoding antibodies to the human glucagon receptor
granted -
US 10640558
Anti-IL-25 antibodies and uses thereof
granted -
US 10633434
Anti-C5 antibodies
granted -
US 10632194
Anti-ErbB3 antibodies and uses thereof
granted -
US 10626173
Method for treating pathological angiogenesis by administering an antibody that inhibits APLNR
granted -
US 10618968
Antigen-binding proteins that activate the leptin receptor
granted -
US 10588940
Use of angiopoietins in promoting blood coagulation and in the treatment of blood coagulation disorders
granted -
US 10582702
Non-human animals having an engineered ANGPTL8 gene
granted -
US 10584173
Nucleic acids encoding high affinity antibodies to human IL-6 receptor
granted -
US 10570151
Biologically active molecules, conjugates thereof, and therapeutic uses
granted